|
|
News Breaks | | | | November 27, 2012 | | 07:37 EDT |  | SQNM, AET, CI | New guidelines on Sequenom test to be considered by insurers, WP says
New prenatal tests for genetic defects that require only a sample of the mother’s blood, as opposed to an invasive procedure, have come under scrutiny from major insurance companies for their high cost and limited data on accuracy and impact on care, reported The Washington Post. A new opinion from the The American College of Obstetricians and Gynecologists will be considered by insurers including Cigna (CI) and Aetna (AET) but is not considered "a clear endorsement” of the tests offered by Sequenom (SQNM) and others, according to the report. Reference Link | |
|
News For SQNM;CI;AET From The Last 14 Days Check below for free stories on SQNM;CI;AET the last two weeks. |
|
|
| There are no results for SQNM;CI;AET |
|
|
|
|
|
|
